Assistant Professor of Medicine
Columbia University Irving Medical Center
New York, NY, United States
Dr. Jason Zucker is an Assistant Professor of Medicine in the Division of Infectious Diseases at Columbia University Medical Center and Assistant Medical Director of the New York City STD Prevention Training Center. Dr. Zucker trained as a combined adult and pediatric infectious diseases physician and is an experienced HIV, HIV prevention, and sexual health care provider providing status-neutral care to patients of all ages in the NewYork Presbyterian-Columbia Comprehensive Health Program Sexual Health Clinic. His research focuses on the intersection of data science, behavioral science, and implementation science, focusing on ways to optimize engagement in the sexual health cascade of care for individuals both living with or at risk of sexually transmitted infections.
Dr. Zucker has been actively involved in sexual health policy and research. He is a PI/co-PI on two NIH-funded studies, including STIckER, a digital patient decision aid designed to improve STI testing in the ED, and Doxy4STICare, which focus on engagement, effective use, and resistance in Doxy-PEP. He has co-written the “Questions, Answers, and Best Practices for Expedited Partner Therapy (EPT)” for the New York State AIDS Institute clinical guidelines program and participated in the New York State Congenital Syphilis Elimination Strategic Planning Group. He is a member of the 2024 STD Prevention Conference Scientific Program Committee and a medical consultant to the CDC for an upcoming version of the STI Treatment Guidelines.
Given his focus on sexual health in New York City, Dr. Zucker has been actively involved since the 2022 mpox outbreak. Dr. Zucker is co-vice chair of the NIH-funded Study of Tecovirimat for Human Monkeypox Virus (STOMP), the randomized, placebo-controlled, double-blinded trial of the safety and efficacy of tecovirimat funded by the NIH and run by the AIDS Clinical Trials Group. He is also a co-investigator and site PI for the CDC-funded Life after Mpox (LAMP) and several other CDC mpox studies. Dr. Zucker also co-wrote the guidance on mpox for the New York State AIDS Institute clinical guidelines program. He is also a member of the Advisory Committee on Immunization Practices for Mpox Working Group and the writing team for the Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV Mpox section.
Disclosure(s): No financial relationships to disclose
24 - Emerging Issues in The Global Mpox Threat
Thursday, October 17, 2024
10:30 AM – 11:45 AM US PT
Thursday, October 17, 2024
3:39 PM – 3:51 PM US PT